NCT05208047 2026-02-04(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal TumorsCogent Biosciences, Inc.Phase 3 Active not recruiting442 enrolled
NCT01694277 2020-12-08Masitinib in Patients With Gastrointestinal Stromal Tumour After Progression With ImatinibAB SciencePhase 3 Completed258 enrolled